Cargando…

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age

BACKGROUND: The International Maternal, Pediatric, and Adolescent Clinical Trials P1060 trial demonstrated superior outcomes for HIV-infected children less than 3 years old initiating antiretroviral therapy (ART) with lopinavir/ritonavir compared to nevirapine, but lopinavir/ritonavir is four-fold c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciaranello, Andrea L., Doherty, Kathleen, Penazzato, Martina, Lindsey, Jane C., Harrison, Linda, Kelly, Kathleen, Walensky, Rochelle P., Essajee, Shaffiq, Losina, Elena, Muhe, Lulu, Wools-Kaloustian, Kara, Ayaya, Samuel, Weinstein, Milton C., Palumbo, Paul, Freedberg, Kenneth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Epidemiology and Social
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536981/ https://www.ncbi.nlm.nih.gov/pubmed/25870982 http://dx.doi.org/10.1097/QAD.0000000000000672

Ejemplares similares

Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations
por: Doherty, Kathleen, et al.
Publicado: (2014)

Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection
por: Ciaranello, Andrea L., et al.
Publicado: (2013)

Untangling the Relationship Between Antiretroviral Therapy Use and Incident Pregnancy: A Marginal Structural Model Analysis Using Data From 47,313 HIV-Positive Women in East Africa
por: Elul, Batya, et al.
Publicado: (2016)

HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
por: Sax, Paul E., et al.
Publicado: (2014)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa
por: Dugdale, Caitlin M., et al.
Publicado: (2019)

Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus
por: Desmonde, Sophie, et al.
Publicado: (2019)

Age-specific mortality rate ratios in adolescents and youth aged 10–24 years living with perinatally versus nonperinatally acquired HIV
por: Desmonde, Sophie, et al.
Publicado: (2021)

Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa
por: Vreeman, Rachel C., et al.
Publicado: (2018)

Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa
por: Stanic, Tijana, et al.
Publicado: (2021)

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa
por: Schomaker, Michael, et al.
Publicado: (2013)

Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART
por: Nuwagaba‐Biribonwoha, Harriet, et al.
Publicado: (2018)

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
por: Hom, Jeffrey K., et al.
Publicado: (2012)

A Global Research Agenda for Pediatric HIV
por: Penazzato, Martina, et al.
Publicado: (2018)

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers
por: Soeteman, Djøra I., et al.
Publicado: (2020)

Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model‐based analysis to inform paediatric HIV screening programmes
por: McCann, Nicole C., et al.
Publicado: (2022)

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal
por: Losina, Elena, et al.
Publicado: (2009)

Survival benefits of antiretroviral therapy in Brazil: a model-based analysis
por: Luz, Paula M, et al.
Publicado: (2016)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
por: Ciaranello, Andrea L, et al.
Publicado: (2011)

The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
por: Dunning, Lorna, et al.
Publicado: (2017)

Reducing mortality in HIV-infected infants and achieving the 90–90–90 target through innovative diagnosis approaches
por: Essajee, Shaffiq, et al.
Publicado: (2015)

Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023)

HIV Testing for Children in Resource-Limited Settings: What Are We Waiting For?
por: Kellerman, Scott, et al.
Publicado: (2010)

Getting back on track to ending AIDS in children: it could just be easier than you think
por: Essajee, Shaffiq, et al.
Publicado: (2023)

Optimizing drugs to reach treatment targets for children and adolescents living with HIV
por: Penazzato, Martina, et al.
Publicado: (2015)

Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected kenyan adults not initially requiring combination antiretroviral therapy
por: Gupta, Samir K, et al.
Publicado: (2011)

Monitoring Virologic Responses to Antiretroviral Therapy in HIV-Infected Adults in Kenya: Evaluation of a Low-Cost Viral Load Assay
por: Sivapalasingam, Sumathi, et al.
Publicado: (2009)

Frequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western Kenya
por: Ayuo, Paul, et al.
Publicado: (2013)

Evolution of resistance in paediatric patients with failure on antiretroviral therapy
por: Orrell, C, et al.
Publicado: (2012)

Time‐varying age‐ and CD4‐stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium
por: Desmonde, Sophie, et al.
Publicado: (2020)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?
por: Braithwaite, R Scott, et al.
Publicado: (2011)

Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis
por: Walensky, Rochelle P., et al.
Publicado: (2010)

HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?
por: Neilan, Anne M, et al.
Publicado: (2018)

Improving Retention in Care Among Pregnant Women and Mothers Living With HIV: Lessons From INSPIRE and Implications for Future WHO Guidance and Monitoring
por: Rollins, Nigel C., et al.
Publicado: (2017)

Contraception use and HIV outcomes among women initiating dolutegravir‐containing antiretroviral therapy in Kenya: a retrospective cohort study
por: Humphrey, John M., et al.
Publicado: (2022)

Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil
por: Cardoso, Sandra W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gtdjkdhl70gjvr02eknnc86ja2